Literature DB >> 7543604

Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer.

K Imai1, Y Ichinose, Y Kubota, H Yamanaka, J Sato.   

Abstract

PURPOSE: The significance of prostate specific antigen (PSA) in the mass screening for prostate cancer was investigated.
MATERIALS AND METHODS: A total of 4,375 PSA, digital rectal and transrectal ultrasonographic examinations was performed on 3,526 subjects.
RESULTS: Among the 3 modalities, PSA had the highest sensitivity (80.4%) and positive predictive value (45.1%). We established age-specific reference PSA ranges for normal Japanese men, and demonstrated the significance of PSA density and PSA velocity.
CONCLUSIONS: The significance of PSA as a prostate cancer screening modality should be evaluated across multiple age ranges and in combination with previous PSA data and/or prostate volume.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543604

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Prostate biopsy in subjects with abnormal transrectal ultrasonography but normal digital examination findings and prostate-specific antigen levels.

Authors:  Hong Bang Shim; Sang Eun Lee; Hyoung Keun Park; Ja Hyeon Ku
Journal:  Int Urol Nephrol       Date:  2007-07-03       Impact factor: 2.370

2.  Detection of prostate cancer by an FDG-PET cancer screening program: results from a Japanese nationwide survey.

Authors:  Ryogo Minamimoto; Michio Senda; Seishi Jinnouchi; Takashi Terauchi; Tomio Inoue
Journal:  Asia Ocean J Nucl Med Biol       Date:  2014

3.  Prostate cancer in Asia: A collaborative report.

Authors:  Rui Chen; Shancheng Ren; Ming Kwong Yiu; Ng Chi Fai; Wai Sam Cheng; Lap Hong Ian; Seiji Naito; Tadashi Matsuda; Elijah Kehinde; Ali Kural; Jason Yichun Chiu; Rainy Umbas; Qiang Wei; Xiaolei Shi; Liqun Zhou; Jian Huang; Yiran Huang; Liping Xie; Lulin Ma; Changjun Yin; Danfeng Xu; Kexin Xu; Zhangqun Ye; Chunxiao Liu; Dingwei Ye; Xin Gao; Qiang Fu; Jianquan Hou; Jianlin Yuan; Dalin He; Tiejun Pan; Qiang Ding; Fengshuo Jin; Benkang Shi; Gongxian Wang; Xiuheng Liu; Dongwen Wang; Zhoujun Shen; Xiangbo Kong; Wanhai Xu; Yaoliang Deng; Haibo Xia; Alexa N Cohen; Xu Gao; Chuanliang Xu; Yinghao Sun
Journal:  Asian J Urol       Date:  2015-04-16

4.  Determination of Serum Prostate Specific Antigen Levels Amongst Apparently Healthy Nigerian Males in a University and University Hospital Community in the Federal Capital Territory.

Authors:  Oseremen I Aisuodionoe-Shadrach; Sefiu B Eniola; Maxwell M Nwegbu; Hadijat O Kolade-Yunusa; Oriaku O Okereke; Thairu Yunusa
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

5.  Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening.

Authors:  N Pashayan; S W Duffy; P Pharoah; D Greenberg; J Donovan; R M Martin; F Hamdy; D E Neal
Journal:  Br J Cancer       Date:  2009-03-17       Impact factor: 7.640

6.  Decision analysis for treatment of early stage prostate cancer.

Authors:  N Yoshimura; N Takami; O Ogawa; Y Kakehi; Y Okada; T Fukui; O Yoshida
Journal:  Jpn J Cancer Res       Date:  1998-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.